webinar register page

NeuroAbilities: Virtual Symposium

"Unlocking the BCI and Neurotech Market for Persons with Disabilities"

Virtual 3-Day Symposium via Zoom
11:00 AM– 12:30 PM Eastern Time (U.S. & Canada) for all 3 days

Wednesday, March 30, 2022
Theme: The Neurotech Opportunity for Persons with Disabilities

Thursday, March 31, 2022
Theme: Regulatory Frameworks & Alternative Paths for Direct-to-Consumer Technologies

Friday, April 1, 2022
Theme: Neuroethics & Disability Rights

Registration is free and provides access to all 3 days.

As Brain-Computer Interfaces (BCI) and Neurotechnology (NT) devices evolve rapidly, what are their pathways to marketable solutions for Persons with Disabilities? What is their market potential? How can their design and applications best serve Persons with Disabilities? How can barriers to adoption be lifted and neuroethics challenges resolved?

The 2022 NeuroAbilities Virtual Symposium will explore these issues with experts from different stakeholder groups, featuring keynote presentations from the U.S. Food and Drug Administration, industry leaders, end users, advocates, and funders. The two main pathways for BCI and NT devices development -- as regulated medical devices or unregulated direct-to-consumer (DTC) products – and their specific challenges and opportunities will be featured over the course of our three-day symposium.

Featured Topics:
• NT user demographics among Persons with Disabilities
• Tracking NT innovation with global patent activity
• User Perspectives: Independent living Vs. medical priorities Vs. consumer products
• Paths to scaling up for BCI and NT innovators
• Regulated vs. Unregulated paths to market
• Evolving financing sources for BCI and NT R&D and product development
• Barriers to adoption
• Neuroethics

Live closed captioning and sign language interpretation provided.

This event will be in English.